Efficacy and safety analysis of immune checkpoint inhibitors combined with chemotherapy in the treatment of advanced triple-negative breast cancer: an umbrella meta-analysis - Quiz - MDSpire

Assessment of the Safety and Effectiveness of Combining Immune Checkpoint Inhibitors with Chemotherapy for Advanced Triple-Negative Breast Cancer: A Comprehensive Meta-Analysis

  • By

  • Wendi Cao

  • Qingxi Rong

  • Yingheng Song

  • Zhijun Ma

  • Qiuxia Dong

  • July 21, 2026

Share

Original Source(s)

Efficacy and safety analysis of immune checkpoint inhibitors combined with chemotherapy in the treatment of advanced triple-negative breast cancer: an umbrella meta-analysis

  • by Wendi Cao, Qingxi Rong, Yingheng Song, Zhijun Ma, Qiuxia Dong

  • July 21, 2026

Related Content

The Secrets of the Gut

Going beyond the gut: why microbiome testing is the next big thing in drug development

Non-anticoagulant heparins: glycan-mediated immune modulation and therapeutic applications

Development and validation of a nomogram for predicting axillary reverse mapping lymph node metastasis in breast cancer patients